Carlotta Cerva
Rome, 00149, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A Case of Pulmonary Fibrosis and COVID-19-Related Pneumonia in a Pembrolizumab-Treated Patient.
Journal: Infectious disease reports
Published: March 24, 2025
Clinical outcomes and adverse events of nontuberculous mycobacterial lung disease treated at an Italian tertiary referral center.
Journal: Scientific reports
Published: March 13, 2025
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series.
Journal: Infectious disease reports
Published: January 30, 2025
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital.
Journal: Infectious disease reports
Published: December 03, 2024
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials.
Journal: Journal of medical virology
Published: November 14, 2024
Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital.
Journal: Antibiotics (Basel, Switzerland)
Published: November 02, 2024
Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease.
Journal: Pathogens (Basel, Switzerland)
Published: October 18, 2024
Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis.
Journal: BMC infectious diseases
Published: July 05, 2024
Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective Study.
Journal: Infectious disease reports
Published: September 23, 2023
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 31, 2023
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study).
Journal: EClinicalMedicine
Published: November 29, 2022
Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital.
Journal: Antibiotics (Basel, Switzerland)
Published: February 20, 2022
Last Updated: 09/26/2026